Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.
Barreyro L, Sampson AM, Ishikawa C, Hueneman KM, Choi K, Pujato MA, Chutipongtanate S, Wyder M, Haffey WD, O'Brien E, et al. Sci Transl Med. 2022 Mar 9; 14(635):eabb7695. Epub 2022 Mar 9.